The latest precision medicine news

Foundation Medicine and InformedDNA® Collaborate to Improve Access to Genetic Counseling for Advanced Cancer Patients

Partnership improves access to genetic counseling services when suspected hereditary cancer gene variant is identified through Foundation Medicine’s tumor testing CAMBRIDGE, Mass. & ST. PETERSBURG, Fla...read more

AGBT 2021 – A Virtual Summary with Spatial Profiling Dominating

AGBT 2021 took place virtually this year! But the conference was nevertheless the attention grabber of the week with a twitter storm, active reporting, and several commercial product launches as demonstrated by a slew...read more

Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

REDWOOD CITY, Calif.–(BUSINESS WIRE)– Guardant Health, Inc. (Nasdaq: GH) has CE-marked Guardant360® CDx for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients with any...read more

Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services

Strategic collaboration combines germline genetic testing, next-generation tumor sequencing and world-class testing capabilities to elevate global precision oncology care SALT LAKE CITY, March 02, 2021 (GLOBE NEWSWIRE)...read more

NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference

March 01, 2021 Data in Twenty-One Poster and Oral Presentations Highlight use of GeoMx Digital Spatial Profiler and the Spatial Molecular Imager Platform for Discovery and Translational Applications...read more

Genomics plc completes oversubscribed $30M funding round

Published 1 Mar 2021 Genomics plc, a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools, is pleased to announce that it has successfully completed a...read more

WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector

In Shanghai, on February 23, 2021 – WuXi Diagnostic Investment (Cayman) Limited (“WuXi Diagnostics”) announced that it has completed US$150 million in series B funding, joined by new investors including...read more

Human Pangenome Reference Consortium Announced Global Release of Year 1 Sequencing Data

Overview: Researchers from the Human Pangenome Reference Consortium announce the open access publication of Year 1 Sequencing data from 30 samples, representing the first major data release from this project. In...read more

NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021

February 22, 2021 Whole Transcriptome Atlas Extends Leadership in Spatial Genomics by Enabling Highly Sensitive Genome-Wide RNA Profiling on GeoMx Digital Spatial Profiler SEATTLE–(BUSINESS WIRE)– NanoString...read more

QIAGEN announces Digital Partner Program with five initial partnerships

Partner program designed to advance Sample to Insight solutions from research to patients leveraging QIAGEN’s unique Knowledge Base • Five initial partners sign with QIAGEN Digital Insights (QDI) to grow QIAGENs unique...read more

Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19

Thursday, February 18, 202 Labcorp Using PacBio’s HiFi Sequencing to Detect SARS-CoV-2 Variants in the U.S. MENLO PARK, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a...read more

Enlightenbio Releases New Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics

New, qualitative report provides an in-depth analysis across the complex, multi-step clinical genomics data process, including genomic data generation and analysis, data flow, and data warehousing. Palo Alto, CA...read more

Micronoma Raises $3.5 Million in Convertible Note Financing

Investors more than double funding base for cancer microbiome diagnostic company to accelerate go-to-market timeline six months after seed February 17, 2021 — San Diego, Calif. Micronoma, the first cancer detection...read more

Exact Sciences To Acquire Ashion Analytics And Enter Research Collaboration With City Of Hope’s Genomics Institute, TGen

Provides Access to Industry-Leading Sequencing Lab and Plans for 10-Year Partnership with National Cancer Research Leaders 02/16/2021 MADISON, Wis., Feb. 16, 2021 /PRNewswire/ — Exact Sciences Corp...read more

Leading Health Providers Unite to Advance Patient Care by Forming Truveta

New data platform will help deliver personalized medicine, advance health equity, and empower the health community with insights on how to best treat patients Leading health providers have come together in unprecedented...read more

Pacific Biosciences Announces $900 Million Investment from SoftBank to Support Growth Initiatives

Wednesday, February 10, 2021 MENLO PARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”), a leading provider of high-quality, long-read sequencing...read more

Personal Genome Diagnostics Announces Close of $103 Million Series C Financing

Proceeds to Support Expansion of Commercial Infrastructure Driving Decentralization of Comprehensive Genomic Profiling for Cancer PGDx’s elio™ Platform and Bioinformatics Solution Enable Hospitals and Labs to Deliver...read more

Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth

Transaction combines Sema4’s leading AI- and machine learning-powered integrated genomic and clinical open-architecture data platform, with CM Life Sciences, the leading life science- focused SPAC, led by institutional...read more

Tempus Launches Hereditary Cancer Germline Assay, xG

February 9, 2021 Tempus, a leader in artificial intelligence and precision medicine, today announced the launch of its new germline sequencing assay, xG, a 52-gene panel that specifically identifies genetic variants...read more

Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III

Nautilus Biotechnology has entered into a definitive merger agreement with Arya Sciences Acquisition Corp III (Nasdaq: ARYA). Upon closing, the combined company is expected to be listed on Nasdaq under the ticker symbol...read more

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle

Commitment from Cornerstone Investor LifeArc to Advance Genomics Startups in the UK SAN DIEGO–(BUSINESS WIRE)– Feb. 8, 2021 — Illumina, Inc. (NASDAQ: ILMN) has selected nine new genomics companies to...read more

23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics

23andMe is a leading consumer genetics and research company that offers a personalized health and wellness experience and has built a premier genetic database to unlock insights leading to the rapid discovery of...read more

Veracyte to Acquire Decipher Biosciences

Further solidifies global leadership in differentiated, genomics-driven cancer diagnostics Expands TAM with presence in 7 of the 10 most common cancers Expected to accelerate revenue growth Tina Nova, Ph.D., Decipher...read more

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Agreement with Gabriel Precision Oncology to support the routine use of advanced cancer genomics in healthcare Cambridge, United Kingdom – 03 February 2021 – Congenica, the digital health company enabling rapid and...read more

GATC Health and Liquid Biosciences Partner to Improve Drug Development & Precision Medicine Research

The Collaboration Will Leverage Innovative Technology Platforms to Help Pharma Companies Develop Drugs Faster, More Efficiently and With Higher Success Rates January 27, 2021 07:01 AM Eastern Standard Time IRVINE, Calif...read more

Split Biosciences, now Parse Biosciences, Announces $7M in Series A Funding to Democratize Single-Cell RNA Sequencing

As adoption of scRNA-seq in industry and academia accelerates, Parse Biosciences (formerly Split Bio) offers the most flexible and scalable single cell sequencing kit, no custom instrument needed Seattle, WA, January...read more

Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19

Quest’s genomic sequencing and infectious disease expertise will identify novel SARS-CoV-2 mutations, providing insights on prevalence and transmission in the United States SECAUCUS, N.J., Jan. 18...read more

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Project aims to standardize MRD data generation, assessment and accelerate AML clinical trial programs bringing novel therapies to patients in need faster SAN FRANCISCO, Jan. 14, 2021 /PRNewswire/ — Invitae...read more

Personal Genome Diagnostics and QIAGEN Collaborate to Offer Integrated Genomic Testing and Interpretation Support

Partnership to Accelerate Adoption of Next-Generation Sequencing (NGS) in Clinical Decision-Making Comprehensive Pan-Cancer Tumor Profiling Assays can be Combined with Clinical Informatics Platform with Potential to...read more

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

New platform expected to make whole genome sequencing significantly more affordable and accessible for use in mainstream medical care MENLO PARK, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of...read more

Our Top Selection of Precision Medicine News

Precision medicine, omics, and genetics news from around the world.